True Leaf Pet is a division of True Leaf Medicine International Ltd.  Visit www.trueleaf.com for more info.

Innovative True Hemp™ Product Comes to German Market in Deal with Pro Pet Koller

December 20, 2016

Innovative True Hemp™ Product Comes to German Market in Deal with Pro Pet Koller

Hemp-based functional treats for dogs now in Germany, Austria as well as the United Kingdom. Further European expansion planned for 2017

Vancouver, December 20, 2016 – True Leaf Pet Europe LLC Sàrl., the Luxembourg company that produces and sells hemp-based functional treats for dogs, has completed an agreement with Pro Pet Koller, the top German supplier of premier pet food, to distribute and sell True Leaf Pet products in Germany and Austria.

Under the terms of the agreement, Pro Pet will start distributing True Hemp products in stores, building the number month by month. Pro Pet supplies a total of 1700 stores directly and through its wholesale network.

“Pro Pet represents an important step in the building of our distributor network in Europe,” said True Leaf CEO Darcy Bomford. “We now have good coverage of two of the biggest markets in Europe with Pet’s Corner in the United Kingdom and now Pro Pet in Germany and Austria. As well, we are in discussion with other great partners and expect to launch in other European countries in 2017,” he added.

Pro Pet is a family-run business founded in 1993 by Werner Koller, who was joined in 2016 by his oldest son Michael.

“True Hemp is a truly innovative treat that we can offer to our customers in Germany and Austria,” said Michael Koller. “This range of hemp-based treats for dogs meets the real needs of the consumer and will help our retail customers be a force in the burgeoning market for functional treats. Hemp brings real benefits for pets and we are excited by the opportunity.”

Hemp is coming into its own as health-conscious consumers worldwide recognize the benefits of the plant. The crushed hemp seeds yield an emerald-green oil that is rich in omega 3 fatty acids, stearidonic acid (SDA) and a rare plant source of gamma linolenic acid (GLA) – all seen to have potential anti-inflammatory properties. Ground hemp seeds yield one of nature’s highest sources of highly digestible, gluten-free protein and fibre, both essential to a healthy diet.

“What really sets our products apart from the crowd are not only the ground hemp seed and hemp leaf inclusions, but the other ingredients we infuse into the formulations to address specific functions,” said Mr. Bomford. “These include New Zealand green-lipped mussel and turmeric root for hip and joint function, DHA and pomegranate for health support, and L-theanine, chamomile and lemon balm for a calming function.”

About True Leaf
True Leaf Medicine International Ltd., through its wholly-owned subsidiary ‘True Leaf Pet’, has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Europe, Canada, and the United States. The company has also filed an application under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its ‘True Leaf Medicine’ subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada’s review and is currently awaiting security clearance and ‘pre-licensing inspection’ approval.

Media Contact:
Paul Sullivan
BreakThrough Communications
O: 604-685-4742
M: 604-603-7358

Investor Contact:
Kevin Bottomley
Director and Corporate Relations
M: 778-389-9933
E: kevin@trueleaf.com





Also in News

True Leaf Announces First Tranche Closing of Private Placement and Stock Option Grants
True Leaf Announces First Tranche Closing of Private Placement and Stock Option Grants

May 30, 2017

True Leaf Medicine International Ltd. (the "Company") (MJ: CSE)(TLA: FSE) is pleased to announce that it has closed the first tranche of its recently-announced non-brokered private placement...

Continue Reading

TRUE LEAF ANNOUNCES PRIVATE PLACEMENT
TRUE LEAF ANNOUNCES PRIVATE PLACEMENT

May 03, 2017

Vancouver, BC, May 3, 2017 – True Leaf Medicine International Ltd. (the "Company") (MJ: CSE)(TLA: FSE) is pleased to announce that it intends to complete a non-brokered private placement...

Continue Reading

Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage
Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage

April 23, 2017

True Leaf Medicine International Ltd. (CSE: MJ, FSE: TLA), has engaged a number of cannabis experts to guide the company through the final stages in Health Canada’s review of its application for a license to produce marijuana in Canada.

Continue Reading